Influenza Clinical Trial
Official title:
Cluster RCT Evaluating the Effectiveness of "Successful Influenza Immunization Campaigns in Healthcare Organizations: A Guide for Campaign Planners, Part of Optimizing Healthcare Workers Interpandemic Vaccine Uptake Study
During the 2010-2011 and the 2011-2012 seasonal influenza immunization campaigns, we will
recruit a minimum of 46 healthcare organizations to either conduct their campaigns as usual
or to use the "Successful Influenza Immunization Campaigns for Healthcare Personnel: A Guide
for Campaign Planners and a web-based grab-and-go Tool Kit. At the end of the campaign
season we will evaluate the impact of the Guide and web-based tools and assess whether there
were changes in immunization rates within each organization and/or if there were significant
changes in the management of the campaigns across organizations.
Following completion of the study, we will work with partner organizations to make these
tools available to all Canadian healthcare organizations.
Keeping nurses, physicians and allied health professionals working during seasonal influenza
epidemics is essential. Influenza immunization has been shown to mitigate the adverse health
outcomes associated with influenza in the community. When provided to healthcare personnel,
influenza vaccine reduces the frequency and severity of influenza outbreaks and reduces
influenza-associated morbidity and mortality among patients by reducing the transmission of
influenza from healthcare personnel to their vulnerable patients.
Despite abundant evidence of the safety and efficacy of the influenza vaccine, immunization
rates among healthcare personnel in hospital and long-term settings remain well below the
public health target of 90%. Current initiatives targeted at increasing healthcare personnel
immunization rates are having limited success with healthcare personnel immunization rates
as low as 2%, but averaging 40% - 60% in most healthcare facilities being reported.
Following the work of the research team over the past two years, a Guide, called "Successful
Influenza Immunization Campaigns for Healthcare Personnel: A Guide for Campaign Planners"
has been developed, along with web-based "grab and go" tools (the Toolkit). This practical
Guide is structured to facilitate the use of the evidence-based research on strategies to
increase immunization rates by healthcare planners.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05523089 -
The Effectiveness of CD388 to Prevent Flu in an Influenza Challenge Model in Healthy Adults
|
Phase 2 | |
| Completed |
NCT05009251 -
Using Explainable AI Risk Predictions to Nudge Influenza Vaccine Uptake
|
N/A | |
| Completed |
NCT03282240 -
Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Participants ≥65 Years in the US
|
Phase 3 | |
| Completed |
NCT00968526 -
Study to Evaluate Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Adults
|
Phase 3 | |
| Completed |
NCT00968539 -
Study to Evaluate the Immunogenicity & Safety of an Investigational Influenza Vaccine (H1N1) in Adults
|
Phase 3 | |
| Completed |
NCT00971425 -
Evaluation of the Immune Response and the Safety of a Pandemic Influenza Candidate Vaccine (H1N1)
|
Phase 3 | |
| Completed |
NCT05525494 -
Patient Portal Flu Vaccine Reminders (5)
|
N/A | |
| Completed |
NCT04074928 -
Safety and Immunogenicity Study of QIVc in Healthy Pediatric Subjects
|
Phase 3 | |
| Completed |
NCT04695717 -
This Study Was Conducted to Evaluate the Safety and Immunogenicity of IVACFLU-S Produced in Children From 6 Months to Under 18 Years Old and the Elderly Over 60 Years Old in Vietnam
|
Phase 3 | |
| Completed |
NCT05012163 -
Lottery Incentive Nudges to Increase Influenza Vaccinations
|
N/A | |
| Completed |
NCT04109222 -
Collection of Serum Samples From Children and Older Adults Receiving the 2019-2020 Formulations of Fluzone® Quadrivalent and Fluzone® High-Dose Influenza Vaccines, Respectively
|
Phase 4 | |
| Completed |
NCT03888989 -
Response to Influenza Vaccine During Pregnancy
|
Phase 1 | |
| Completed |
NCT02587221 -
Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared to Non-influenza Vaccine Comparator in Adults ≥ 65 Years of Age
|
Phase 3 | |
| Completed |
NCT03453801 -
The Role of CD4+ Memory Phenotype, Memory, and Effector T Cells in Vaccination and Infection
|
Phase 1 | |
| Completed |
NCT01440387 -
A Study of Immunogenicity and Safety of GSK Biologicals' Influenza Vaccine FLU-Q-QIV in Adults Aged 18 Years and Older
|
Phase 3 | |
| Terminated |
NCT01195779 -
Trial to Evaluate Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2584786A in Healthy Children
|
Phase 2 | |
| Completed |
NCT03321968 -
Lot-to-lot Consistency of a Plant-Derived Quadrivalent Virus-Like Particles Influenza Vaccine in Healthy Adults
|
Phase 3 | |
| Completed |
NCT00972517 -
Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Children
|
Phase 3 | |
| Completed |
NCT04570904 -
Broadening Our Understanding of Early Versus Late Influenza Vaccine Effectiveness
|
||
| Recruiting |
NCT03331991 -
Prevention of Influenza and Other Wintertime Respiratory Viruses Among Healthcare Professionals in Israel
|
N/A |